# The immunopathological crosstalk of diabetic periodontitis: Single-cell insights into monocyte dysregulation

**Authors:** Chenli Si, Xinlei Wu, Huijuan Cheng, Wentao Jiang, Huijiao Yan

PMC · DOI: 10.1371/journal.pone.0341333 · PLOS One · 2026-02-17

## TL;DR

This study uses single-cell RNA sequencing to explore how diabetes affects immune cells in periodontitis, revealing new insights into immune cell changes and signaling pathways.

## Contribution

The study provides novel insights into monocyte dysregulation and signaling pathway alterations in diabetic periodontitis using single-cell RNA sequencing.

## Key findings

- PDDM patients show increased classical monocytes and decreased nonclassical monocytes compared to PD patients.
- PDDM-enriched classical monocytes upregulate oxygen transport pathways while suppressing chemotaxis and cytokine responses.
- Reduced TGF-β signaling and enhanced CCL pathway activation promote chronic inflammation and tissue destruction in PDDM.

## Abstract

Periodontitis (PD) and type 2 diabetes mellitus (DM) are bidirectionally associated through shared chronic inflammatory mechanisms. Although monocytes serve as central immune mediators in both pathologies, their functional heterogeneity and dynamic alterations in diabetic periodontitis (PDDM) remain poorly characterized. Utilizing single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) from healthy controls, PD patients, and PDDM subjects, we systematically investigated the immunopathological crosstalk between these comorbidities. Our analysis revealed a significant shift in monocyte subpopulations, with PDDM patients exhibiting increased classical monocytes (CD14++CD16−) and decreased nonclassical monocytes (CD14 + CD16++) compared to PD counterparts. Functional profiling demonstrated PDDM-enriched classical monocytes upregulated oxygen transport pathways while suppressing chemotaxis and cytokine responses, whereas nonclassical monocytes showed impaired oxidative phosphorylation and nucleotide biosynthesis. Cell communication analysis identified reduced activity of TGF-β signaling and enhanced CCL pathway activation, collectively promoting chronic inflammation and tissue destruction. Regulatory network reconstruction revealed transcription factors (PBX1, TAL1, IRF9) governing monocyte differentiation defects and hyperinflammatory phenotypes. These results suggest mechanistic links how diabetic conditions exacerbate periodontal inflammation through monocyte reprogramming and signaling pathway dysregulation, providing a cellular roadmap for developing targeted immunotherapies in PDDM management.

## Linked entities

- **Genes:** PBX1 (PBX homeobox 1) [NCBI Gene 5087], TAL1 (TAL bHLH transcription factor 1, erythroid differentiation factor) [NCBI Gene 6886], IRF9 (interferon regulatory factor 9) [NCBI Gene 10379]
- **Diseases:** periodontitis (MONDO:0005076), type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** TCF7L2 (transcription factor 7 like 2) [NCBI Gene 6934] {aka TCF-4, TCF4}, IRF1 (interferon regulatory factor 1) [NCBI Gene 3659] {aka IMD117, IRF-1, MAR}, HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}, IRF9 (interferon regulatory factor 9) [NCBI Gene 10379] {aka IRF-9, ISGF3, ISGF3G, p48}, CIITA (class II major histocompatibility complex transactivator) [NCBI Gene 4261] {aka C2TA, CIITAIV, MHC2D1, MHC2TA, NLRA}, TMEM176A (transmembrane protein 176A) [NCBI Gene 55365] {aka GS188, HCA112, MS4B1}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, HBB (hemoglobin subunit beta) [NCBI Gene 3043] {aka CD113t-C, ECYT6, beta-globin}, TAL1 (TAL bHLH transcription factor 1, erythroid differentiation factor) [NCBI Gene 6886] {aka SCL, TCL5, bHLHa17, tal-1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, RETN (resistin) [NCBI Gene 56729] {aka ADSF, FIZZ3, RENT, RETN1, RSTN, XCP1}, BACH1 (BTB domain and CNC homolog 1) [NCBI Gene 571] {aka BACH-1, BTBD24}, IFI30 (IFI30 lysosomal thiol reductase) [NCBI Gene 10437] {aka GILT, IFI-30, IP-30, IP30}, NCAM1 (neural cell adhesion molecule 1) [NCBI Gene 4684] {aka CD56, MSK39, NCAM}, EGR1 (early growth response 1) [NCBI Gene 1958] {aka AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268}, PVR (PVR cell adhesion molecule) [NCBI Gene 5817] {aka CD155, HVED, NECL5, Necl-5, PVS, TAGE4}, HBA2 (hemoglobin subunit alpha 2) [NCBI Gene 3040] {aka ECYT7, HBA-T2, HBH}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, CRYGEP (crystallin gamma E, pseudogene) [NCBI Gene 200575] {aka CCL, CRYG5, CRYGEP1, D2S1472, G2}, TMEM176B (transmembrane protein 176B) [NCBI Gene 28959] {aka LR8, MS4B2}, HBA1 (hemoglobin subunit alpha 1) [NCBI Gene 3039] {aka ECYT7, HBA-T3, HBH, METHBA}, KDM6B (lysine demethylase 6B) [NCBI Gene 23135] {aka JMJD3, NEDCFSA, NEDSST}, SIGLEC1 (sialic acid binding Ig like lectin 1) [NCBI Gene 6614] {aka CD169, SIGLEC-1, SN}, MAFB (MAF bZIP transcription factor B) [NCBI Gene 9935] {aka DURS3, KRML, MCTO}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IRF7 (interferon regulatory factor 7) [NCBI Gene 3665] {aka IMD39, IRF-7, IRF-7H, IRF7A, IRF7B, IRF7C}, ALCAM (activated leukocyte cell adhesion molecule) [NCBI Gene 214] {aka CD166, MEMD}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, HLA-DRB5 (major histocompatibility complex, class II, DR beta 5) [NCBI Gene 3127] {aka DRB5, HLA-DRB5*}, PBX1 (PBX homeobox 1) [NCBI Gene 5087] {aka CAKUHED}, TIGIT (T cell immunoreceptor with Ig and ITIM domains) [NCBI Gene 201633] {aka VSIG9, VSTM3, WUCAM}, CD14 (CD14 molecule) [NCBI Gene 929], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}
- **Diseases:** oral diseases (MESH:D009059), metabolic dysregulation (MESH:D021081), metabolic dysfunction (MESH:D008659), chronic inflammation (MESH:D007249), PD (MESH:D010518), hyperglycemia (MESH:D006943), DM (MESH:D003920), T2DM (MESH:D003924), chronic (MESH:D002908), periodontal disease (MESH:D010510), hyperglycemic (MESH:D006944), gum disease (MESH:C537732), insulin resistance (MESH:D007333), cardiovascular disorders (MESH:D002318), chronic periodontitis (MESH:D055113)
- **Chemicals:** nucleotide (MESH:D009711), blood glucose (MESH:D001786), oxygen (MESH:D010100), lipopolysaccharides (MESH:D008070), carbon dioxide (MESH:D002245), glucose (MESH:D005947), ribose phosphate (MESH:C031626), ribonucleotide (MESH:D012265)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12912578/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12912578/full.md

## References

37 references — full list in the complete paper: https://tomesphere.com/paper/PMC12912578/full.md

---
Source: https://tomesphere.com/paper/PMC12912578